삼성서울병원

Ko En

혈액종양내과 김석진 교수

진료분야
악성림프종, 혈구탐식 증후군, 조혈모세포이식, 다발성 골수종, 아밀로이드증
진료일정 04 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
오전
오후
진료일정 05 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
오전
오후

학력

학력
2003.02 고려대학교 의과대학원 박사학위 취득
1997.08 고려대학교 의과대학원 석사학위 취득
1994.02 고려대학교 의과대학 졸업

경력

경력
2017.04 ~현재 삼성서울병원 커뮤니케이션실 실차장
2014.04 ~현재 성균관대학교 의과대학 내과학 교실 교수
2008.03 ~ 2014.03 성균관대학교 의과대학 내과학 교실 부교수, 삼성서울병원 혈액종양내과
2004.09 ~ 2008.01 고려대학교 의과대학 내과학 교실 조교수, 안암병원 혈액종양내과
2003.05 ~ 2004.08 Postdoctoral fellow, Duke University Medical Center, NC, USA
2002.05 ~ 2003.05 고려대학교 의료원 혈액종양내과 전임의
1999.04 ~ 2002.04 공중 보건의사
1994.03 ~ 1999.02 고려대학교 안암 병원 내과 전공의
1994.03 ~ 1995.02 고려대학교 구로 병원 인턴

학회활동

학회활동
2008.01 ~ 현재 미국 혈액학회
2004.01 ~ 현재 대한조혈모세포이식학회
2004.01 ~ 현재 대한혈액학회
2002.01 ~ 현재 대한암학회
1999.01 ~ 현재 대한내과학회

수상이력

수상이력
2017.02 성균관의대 연구부문 우수업적 교수상
2017.01 고의 의학상
2016.12 김진복 암연구상
2016.06 대한암학회 로슈 암학술상
2015.10 대한내과학회 KJIM Best Reviewer award
2014.06 대한암학회 Cancer Research and Treatment Best Reviewer award
2012.09 대한혈액학회 우수연제상
2011.09 제 6회 대한혈액학회 우수연구자 상
2010.03 삼성서울병원 우수업적교수상
2009.08 대한조혈모세포이식학회 최우수연제상
2006.12 대한혈액학회 우수연제상
2006.08 대한조혈모세포이식학회 우수연제상
  • Leuk Lymphoma. 2017 Jun;58(6):1341-1348. doi: 10.1080/10428194.2016.1236380. Epub 2016 Oct 9. Value of interim FDG PET/CT for predicting outcome of patients with angioimmunoblastic T-cell lymphoma Moon SH11, Lee AY1, Kim WS2, Kim SJ2, Cho YS1, Choe YS1, Kim BT1, Lee KH1.
    View PubMed
  • Ann Hematol. 2017 May;96(5):739-747. doi: 10.1007/s00277-017-2940-y. Epub 2017 Feb 9. Sexual problems in male vs. female non-Hodgkin lymphoma survivors: prevalence, correlates, and associations with health-related quality of life Kim IR11, Kim SH2, Ok ON3, Kim SH4, Lee S5, Choi E6, Kim SJ7, Yoon DH8, Lee MH9.
    View PubMed
  • Blood. 2017 Apr 27;129(17):2437-2442. doi: 10.1182/blood-2016-12-756841. Epub 2017 Feb 10. PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing L-asparaginase Kwong YL11, Chan TSY1, Tan D2,3, Kim SJ4, Poon LM5, Mow B6, Khong PL7, Loong F8, Au-Yeung R8, Iqbal J9, Phipps C2,3, Tse E1.
    View PubMed
  • Nutrition. 2017 Apr;36:67-71. doi: 10.1016/j.nut.2016.06.009. Epub 2016 Jun 25. Patient-Generated Subjective Global Assessment as a prognosis tool in patients with multiple myeloma Kim HS11, Lee JY2, Lim SH2, Cho J3, Kim SJ2, Jang JH2, Kim WS2, Jung CW2, Kim K4.
    View PubMed
  • Oncotarget. 2017 Mar 7;8(10):17038-17049. doi: 10.18632/oncotarget.14928. The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in TNFAIP3 followed by mutations in TBL1XR1 and CREBBP Jung H11,2, Yoo HY3, Lee SH3, Shin S4, Kim SC1, Lee S1, Joung JG1, Nam JY1,3, Ryu D1,3, Yun JW1,5, Choi JK2, Ghosh A5, Kim KK5, Kim SJ6, Kim WS6, Park WY1, Ko YH4.
    View PubMed
  • Oncotarget. 2017 Mar 28;8(13):22014-22022. doi: 10.18632/oncotarget.15782. Cell-of-origin of diffuse large B-cell lymphomas determined by the Lymph2Cx assay: better prognostic indicator than Hans algorithm Yoon N11, Ahn S2, Yong Yoo H3, Jin Kim S4, Seog Kim W4, Hyeh Ko Y5.
    View PubMed
  • Psychooncology. 2017 Mar;26(3):330-336. doi: 10.1002/pon.4136. Epub 2016 Apr 13. Unmet needs of non-Hodgkin lymphoma survivors in Korea: prevalence, correlates, and associations with health-related quality of life Kim SH11, Lee S2, Kim SH3, Ok ON4, Kim IR5, Choi E1, Kang YK6, Kim SJ7, Lee MH8.
    View PubMed
  • Oncotarget. 2017 Feb 21;8(8):13782-13791. doi: 10.18632/oncotarget.14636. Clinical impact of serum survivin positivity and tissue expression of EBV-encoded RNA in diffuse large B-cell lymphoma patients treated with rituximab-CHOP Hong JY11, Ryu KJ2, Park C3, Hong M4, Ko YH5, Kim WS6, Kim SJ2,6.
    View PubMed
  • Bone Marrow Transplant. 2017 Feb;52(2):258-263. doi: 10.1038/bmt.2016.260. Epub 2016 Nov 7. Predictors of general discomfort, limitations in activities of daily living and intention of a second donation in unrelated hematopoietic stem cell donation Lee MH11, Jang JH2, Min HJ3, Jang HI2, Nah JH2, Lyu CJ4, Han KS5, Won JH6, Lee YH7, Chong SY8, Mun YC9, Lee WS10, Kim SJ11, Kim I12.
    View PubMed
  • Oncotarget. 2017 Jan 10;8(2):2466-2476. doi: 10.18632/oncotarget.13690. FOXO4 expression is related to stem cell-like properties and resistance to treatment in diffuse large B-cell lymphoma Ryu KJ11, Park C2, Hong M3, Ko YH4, Kim WS5, Kim SJ1,5.
    View PubMed
  • Cancer Res Treat. 2017 Jan;49(1):92-103. doi: 10.4143/crt.2015.476. Epub 2016 May 9. Comparison of Total Body Irradiation (TBI) Conditioning with Non-TBI for Autologous Stem Cell Transplantation in Newly Diagnosed or Relapsed Mature T- and NK-Cell Non-Hodgkin Lymphoma Maeng CH11, Ko YH2, Lim DH3, Kang ES4, Choi JY5, Kim WS6, Kim SJ6,7.
    View PubMed
  • ONCOTARGET, JAN 17 2017, 8(3):5361-5370, DOI: 10.18632/oncotarget.14243 Epstein-Barr virus EBNA2 directs doxorubicin resistance of B cell lymphoma through CCL3 and CCL4-mediated activation of NF-kappa B and Btk Kim JH1, Kim WS, Hong JY, Ryu KJ, Kim SJ, Park C
    View PubMed
  • Mod Pathol. 2017 Jan;30(1):4-14. doi: 10.1038/modpathol.2016.56. Epub 2016 Sep 30. Prognostic impact of MYC protein expression in central nervous system diffuse large B-cell lymphoma: comparison with MYC rearrangement and MYC mRNA expression Son SM11, Ha SY1, Yoo HY2,3, Oh D4, Kim SJ3,5, Kim WS3,5, Ko YH1,3.
    View PubMed
  • Oncotarget. 2016 Dec 20;7(51):85584-85591. doi: 10.18632/oncotarget.11319. Phase II trial of concurrent chemoradiotherapy with L-asparaginase and MIDLE chemotherapy for newly diagnosed stage I/II extranodal NK/T-cell lymphoma, nasal type (CISL1008) Yoon DH11, Kim SJ2, Jeong SH3, Shin DY4, Bae SH5, Hong J6, Park SK7, Yhim HY8, Yang DH9, Lee H10, Kang HJ11, Lee MH12, Eom HS10, Kwak JY8, Lee JH6, Suh C1, Kim WS2.
    View PubMed
  • Oncotarget. 2016 Dec 27;7(52):86433-86445. doi: 10.18632/oncotarget.13239. Whole-exome and transcriptome sequencing of refractory diffuse large B-cell lymphoma Park HY11,2, Lee SB3, Yoo HY4, Kim SJ5, Kim WS5, Kim JI1, Ko YH2.
    View PubMed
  • Ann Oncol. 2016 Nov;27(11):2133-2134. Epub 2016 Aug 8. Reply to the letter to the editor 'Epstein-Barr virus reactivation in extranodal natural killer/T-cell lymphoma patients: a previously unrecognized serious adverse event in a pilot study with romidepsin, histone deacetylase (HDAC) inhibitors when combined with a proteasome inhibitor are safe and effective in patients with extranodal natural killer/T-cell lymphoma' by Tan et al. Kim SJ11,2, Kim WS3.
    View PubMed
  • Oncotarget. 2016 Nov 22;7(47):76934-76943. doi: 10.18632/oncotarget.12734. Prognostic significance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab era Seo S11, Hong JY1, Yoon S1,2, Yoo C1, Park JH1, Lee JB3, Park CS4, Huh J5, Lee Y5, Kim KW6, Ryu JS7, Kim SJ8, Kim WS8, Yoon DH1, Suh C1.
    View PubMed
  • Int J Hematol. 2016 Nov;104(5):591-595. Epub 2016 Jul 25. Clinical features and treatment outcome of Epstein-Barr virus-positive nodal T-cell lymphoma Jung KS11,2, Cho SH2, Kim SJ1, Ko YH3, Kim WS4.
    View PubMed
  • Oncotarget. 2016 Nov 1;7(44):72033-72043. doi: 10.18632/oncotarget.12459. Highly elevated serum lactate dehydrogenase is associated with central nervous system relapse in patients with diffuse large B-cell lymphoma: Results of a multicenter prospective cohort study Kim SJ11, Hong JS2, Chang MH3, Kim JA4, Kwak JY5, Kim JS6, Yoon DH7, Lee WS8, Do YR9, Kang HJ10, Eom HS11, Park Y12, Won JH13, Mun YC14, Kim HJ15, Kwon JH16, Kong JH17, Oh SY18, Lee S19, Bae SH20, Yang DH21, Jun HJ22, Kim YS23, Yun HJ24, Lee SI25, Kim MK26, Park EK27, Kim WS1, Suh C7.
    View PubMed
  • J Infect. 2016 Nov;73(5):496-505. doi: 10.1016/j.jinf.2016.06.011. Epub 2016 Jul 7. Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients Park S11, Kim K1, Jang JH1, Kim SJ1, Kim WS1, Chung DR2, Kang CI2, Peck KR2, Jung CW3.
    View PubMed
  • Oncotarget. 2016 Oct 18;7(42):68350-68359. doi: 10.18632/oncotarget.12029. Recurrent mutations of MAPK pathway genes in multiple myeloma but not in amyloid light-chain amyloidosis Kim SJ11, Shin HT2, Lee HO2, Kim NK2, Yun JW2, Hwang JH3, Kim K1, Park WY2.
    View PubMed
  • Oncotarget. 2016 Sep 13;7(37):59892-59901. doi: 10.18632/oncotarget.10988. Blood concentration of cyclosporine during early post-transplant period may have influence on the occurrence of chronic graft versus host disease in patients who received allogeneic hematopoietic stem cell transplantation Park S11, Kim K1, Jang JH1, Kim SJ1, Kim WS1, Jung CW1.
    View PubMed
  • Acta Haematol. 2016;136(3):186-90. doi: 10.1159/000448159. Epub 2016 Sep 14. Mediastinal Gray Zone Lymphoma with Features Intermediate between Classical Hodgkin Lymphoma and Primary Mediastinal B-Cell Lymphoma Song HN11, Kim SJ, Ko YH, Kim WS.
    View PubMed
  • BMC Cancer. 2016 Aug 8;16:613. doi: 10.1186/s12885-016-2645-y. Risk factors associated with early mortality in patients with multiple myeloma who were treated upfront with a novel agents containing regimen Jung SH11, Cho MS1, Kim HK2, Kim SJ2, Kim K3, Cheong JW4, Kim SJ4, Kim JS4, Ahn JS1, Kim YK1, Yang DH1, Kim HJ1, Lee JJ5; Korean Multiple Myeloma Working Party (KMMWP).
    View PubMed
  • Oncotarget. 2016 Jul 26;7(30):47127-47133. doi: 10.18632/oncotarget.9478. Comprehensive genomic profiling of IgM multiple myeloma identifies IRF4 as a prognostic marker Ryu D11,2, Kim HJ3, Joung JG1, Lee HO1,4, Bae JS1, Kim SJ5, Kim H5, Park WY1,2,4, Kim K5.
    View PubMed
  • Bone Marrow Transplant. 2016 Jun;51(6):807-12. doi: 10.1038/bmt.2016.6. Epub 2016 Feb 8. Prognostic relevance of pretransplant Deauville score on PET-CT and presence of EBV DNA in patients who underwent autologous stem cell transplantation for ENKTL Lim SH11, Hyun SH2, Kim HS1, Lee JY1, Yoo KH1, Jung KS1, Song HN1, Cho J1, Park S1, Ko YH3, Kim SJ1, Choi JY2, Kim WS1.
    View PubMed
  • Haematologica. 2016 Jun;101(6):757-63. doi: 10.3324/haematol.2015.139253. Epub 2016 Jan 27. Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma Yoo HY11, Kim P2, Kim WS3, Lee SH4, Kim S5, Kang SY6, Jang HY7, Lee JE7, Kim J8, Kim SJ3, Ko YH9, Lee S10.
    View PubMed
  • Leuk Lymphoma. 2016;57(6):1413-22. doi: 10.3109/10428194.2015.1113276. Epub 2015 Dec 24. CD79B limits response of diffuse large B cell lymphoma to ibrutinib Kim JH11, Kim WS1,2, Ryu K1, Kim SJ1,2, Park C1.
    View PubMed
  • Haematologica. 2016 Jun;101(6):e271. doi: 10.3324/haematol.2016.148015. Epub 2016 May 31. Author reply to Comment on: Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma, by Yoo et al. Yoo HY11, Kim P2, Kim WS3, Lee SH1, Kim S4, Kang SY5, Jang HY6, Lee JE6, Kim J7, Kim SJ3, Ko YH8, Lee S9.
    View PubMed
  • Mod Pathol. 2016 May;29(5):430-43. doi: 10.1038/modpathol.2016.47. Epub 2016 Mar 25. Nasal-type NK/T-cell lymphomas are more frequently T rather than NK lineage based on T-cell receptor gene, RNA, and protein studies: lineage does not predict clinical behavior Hong M11,2, Lee T1, Young Kang S1, Kim SJ3, Kim W3, Ko YH1.
    View PubMed
  • Ann Lab Med. 2016 May;36(3):209-14. doi: 10.3343/alm.2016.36.3.209. Usefulness of Flow Cytometric Analysis for Detecting Leptomeningeal Diseases in Non-Hodgkin Lymphoma Shin SY11,2, Lee ST2,3, Kim HJ2, Oh YL4, Kim SJ5, Kim WS5, Kim SH6.
    View PubMed
  • Ann Hematol. 2016 May;95(6):911-9. doi: 10.1007/s00277-016-2660-8. Epub 2016 Apr 6. The clinical impact of thalidomide maintenance after autologous stem cell transplantation in patients with newly diagnosed multiple myeloma in real clinical practice of Korea Lee HS11, Min CK2, Lee JJ3, Kim K4, Kim SJ4, Yoon DH5, Eom HS6, Lee H6, Lee WS7, Shin HJ8, Lee JH9, Park Y10, Jo JC11, Do YR12, Mun YC13, Lee MH14
    View PubMed
  • Korean J Intern Med. 2016 May;31(3):560-9. doi: 10.3904/kjim.2014.222. Epub 2016 Feb 22. Treatment outcomes and clinical relevance of the Follicular Lymphoma International Prognostic Index in Korean follicular lymphoma patients treated with chemotherapy Maeng CH11,2, Ahn SW3, Ryu SY3, Han S3, Ko YH4, Ji JH5, Kim WS2, Kim SJ2.
    View PubMed
  • Ann Oncol. 2016 Apr;27(4):712-8. doi: 10.1093/annonc/mdv624. Epub 2016 Feb 8. A phase II study of everolimus (RAD001), an mTOR inhibitor plus CHOP for newly diagnosed peripheral T-cell lymphomas Kim SJ11, Shin DY2, Kim JS3, Yoon DH4, Lee WS5, Lee H6, Do YR7, Kang HJ2, Eom HS6, Ko YH8, Lee SH9, Yoo HY10, Hong M11, Suh C4, Kim WS12.
    View PubMed
  • Cancer Chemother Pharmacol. 2016 Apr;77(4):865-73. doi: 10.1007/s00280-016-3005-y. Epub 2016 Mar 16. Results of a phase II study of vorinostat in combination with intravenous fludarabine, mitoxantrone, and dexamethasone in patients with relapsed or refractory mantle cell lymphoma: an interim analysis Shin DY11, Kim SJ2, Yoon DH3, Park Y4, Kong JH5, Kim JA6, Kim BS7, Kim HJ8, Won JH9, Park SK10, Kim WS11.
    View PubMed
  • J Hematol Oncol. 2016 Apr 18;9:41. doi: 10.1186/s13045-016-0271-4. L-asparaginase-based regimens followed by allogeneic hematopoietic stem cell transplantation improve outcomes in aggressive natural killer cell leukemia Jung KS11,2, Cho SH2, Kim SJ1, Ko YH3, Kang ES4, Kim WS5.
    View PubMed
  • Ann Hematol. 2016 Mar;95(4):581-91. doi: 10.1007/s00277-015-2581-y. Epub 2016 Jan 4. Extra-nodal natural killer/T cell lymphoma in elderly patients: the impact of aging on clinical outcomes and treatment tolerability Kim SM11, Park S1, Oh DR2, Ahn YC2, Ko YH3, Kim SJ1, Kim WS4.
    View PubMed
  • Ann Oncol. 2016 Mar;27(3):508-13. doi: 10.1093/annonc/mdv596. Epub 2015 Dec 9. Epstein-Barr virus reactivation in extranodal natural killer/T-cell lymphoma patients: a previously unrecognized serious adverse event in a pilot study with romidepsin Kim SJ11, Kim JH2, Ki CS3, Ko YH4, Kim JS5, Kim WS6.
    View PubMed
  • Lancet Oncol. 2016 Mar;17(3):389-400. doi: 10.1016/S1470-2045(15)00533-1. Epub 2016 Feb 10. A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis Kim SJ11, Yoon DH2, Jaccard A3, Chng WJ4, Lim ST5, Hong H6, Park Y7, Chang KM8, Maeda Y9, Ishida F10, Shin DY11, Kim JS12, Jeong SH13, Yang DH14, Jo JC15, Lee GW16, Choi CW17, Lee WS18, Chen TY19, Kim K20, Jung SH20, Murayama T21, Oki Y22, Advani R23, d'Amore F24, Schmitz N25, Suh C2, Suzuki R26, Kwong YL27, Lin TY6, Kim WS28.
    View PubMed
  • Oncotarget. 2016 Mar 15;7(11):12359-71. doi: 10.18632/oncotarget.7132. Clonal relationships in recurrent B-cell lymphomas Lee SE11, Kang SY2, Yoo HY3, Kim SJ4, Kim WS4, Ko YH2.
    View PubMed
  • Blood Cancer J. 2016 Feb 12;6:e395. doi: 10.1038/bcj.2016.2. The prognostic value of interim and end-of-treatment PET/CT in patients with newly diagnosed peripheral T-cell lymphoma Ham JS11, Kim SJ1, Choi JY2, Hyun SH2, Choi SK3, Kim HS1, Lim SH1, Lee JY1, Jung SH3, Ko YH4, Kim WS1.
    View PubMed
  • Cancer Res Treat. 2016 Jan;48(1):312-21. doi: 10.4143/crt.2014.266. Epub 2015 Mar 2. Cross-sectional Study of Patients with Diffuse Large B-Cell Lymphoma: Assessing the Effect of Host Status, Tumor Burden, and Inflammatory Activity on Venous Thromboembolism Lim SH11, Woo SY2, Kim S2, Ko YH3, Kim WS1, Kim SJ1.
    View PubMed
  • Ann Hematol. 2016 Jan;95(2):325-35. doi: 10.1007/s00277-015-2523-8. Epub 2015 Oct 10. Clinical significance of bone marrow hemophagocytosis in adult patients with malignancy and non-malignancy-induced hemophagocytic lymphohistiocytosis Lim SH11, Park S1, Jang JH1, Kim K1, Kim HJ2, Kim SH2, Kang CI3, Chung DR3, Peck KR3, Lee J4, Cha HS4, Koh EM4, Ko YH5, Kim WS1, Jung CW1, Kim SJ6,7.
    View PubMed
  • Int J Hematol. 2015 Dec;102(6):678-88. Efficacy and feasibility of autologous stem cell transplantation in patients with diffuse large B-cell lymphoma with secondary central nervous system involvement Lee MY1, Kim HS, Lee JY, Lim SH, Kang ES, Ko YH, Kim SJ, Kim WS.
    View PubMed
  • Oncotarget. 2015 Dec 15;6(40):42803-12. doi: 10.18632/oncotarget.5658. Iron deficient erythropoiesis might play key role in development of anemia in cancer patients Park S11, Jung CW1, Kim K1, Kim SJ1, Kim WS1, Jang JH1.
    View PubMed
  • J Clin Lab Anal. 2015 Nov;29(6):505-10. doi: 10.1002/jcla.21801. Epub 2014 Oct 2. Antigen Expression Patterns of Plasma Cell Myeloma: An Association of Cytogenetic Abnormality and International Staging System (ISS) for Myeloma Shin SY11, Lee ST1, Kim HJ1, Kim SJ2, Kim K2, Kang ES1, Kim SH1.
    View PubMed
  • Leuk Lymphoma. 2015;56(11):3052-7. doi: 10.3109/10428194.2015.1025391. Epub 2015 Apr 8. A subset of CD45+/CD19-cells in bone marrow may be associated with clinical outcomes of patients with mantle cell lymphoma Kim SM11, Lee ST2,3, Ryu KJ4, Kim HJ2, Kim SH2, Ko YH5, Kim WS1, Kim SJ1,6.
    View PubMed
  • Haematologica. 2015 Dec;100(12):e505-7. doi: 10.3324/haematol.2015.133074. Epub 2015 Sep 24. A highly recurrent novel missense mutation in CD28 among angioimmunoblastic T-cell lymphoma patients Lee SH11, Kim JS1, Kim J2, Kim SJ3, Kim WS3, Lee S2, Ko YH4, Yoo HY5.
    View PubMed
  • Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):677-83. doi: 10.1016/j.ijrobp.2015.07.2267. Epub 2015 Jul 22. Concurrent Chemoradiation Therapy Followed by Consolidation Chemotherapy for Localized Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type Oh D11, Ahn YC2, Kim SJ3, Kim WS3, Ko YH4.
    View PubMed
  • Liver Int. 2015 Nov;35(11):2363-9. doi: 10.1111/liv.12838. Epub 2015 Apr 12. Hepatitis B reactivation in multiple myeloma patients with resolved hepatitis B undergoing chemotherapy Lee JY11, Lim SH1, Lee MY1, Kim H1, Sinn DH1, Gwak GY1, Choi MS1, Lee JH1, Jung CW1, Jang JH1, Kim WS1, Kim SJ1, Kim K1.
    View PubMed
  • Transpl Infect Dis. 2015 Oct;17(5):679-87. doi: 10.1111/tid.12424. Epub 2015 Sep 26. Incidence of infection according to intravenous immunoglobulin use in autologous hematopoietic stem cell transplant recipients with multiple myeloma Park S11, Jung CW1, Jang JH1, Kim SJ1, Kim WS1, Kim K1.
    View PubMed
  • Int J Hematol. 2015 Oct;102(4):420-5. doi: 10.1007/s12185-015-1845-6. Epub 2015 Jul 26. Is there role of additional chemotherapy after definitive local treatment for stage I/II marginal zone lymphoma: Consortium for Improving Survival of Lymphoma (CISL) study Koh MS11, Kim WS2, Kim SJ2, Oh SY3, Yoon DH4, Lee SI5, Hong J6, Song MK7, Shin HJ7, Kwon JH8, Kim HJ8, Do YR9, Suh C10, Kim HJ1.
    View PubMed
  • Int Forum Allergy Rhinol. 2015 Oct;5(10):960-6. doi: 10.1002/alr.21564. Epub 2015 Jun 3. Nasal endoscopic evaluation and its impact on survival in patients with stage I/II extranodal natural killer/T-cell lymphoma, nasal type Cho HJ11, Jang MS2, Hong SD2, Kim SJ3, Ahn YC4, Oh D4, Ko YH5, Kim HY2, Dhong HJ2, Chung SK2, Kim WS3.
    View PubMed
  • Hum Immunol. 2015 Sep;76(9):636-43. doi: 10.1016/j.humimm.2015.09.009. Epub 2015 Sep 25. KIR alloreactivity based on the receptor-ligand model is associated with improved clinical outcomes of allogeneic hematopoietic stem cell transplantation: Result of single center prospective study Park S11, Kim K1, Jang JH1, Kim SJ1, Kim WS1, Kang ES2, Jung CW3.
    View PubMed
  • Curr Opin Oncol. 2015 Sep;27(5):392-8. doi: 10.1097/CCO.0000000000000210. Epstein - Barr virus-positive diffuse large B-cell lymphoma of the elderly: a concise review and update Hong JY11, Ko YH, Kim SJ, Kim WS.
    View PubMed
  • Biol Blood Marrow Transplant. 2015 Sep;21(9):1597-604. doi: 10.1016/j.bbmt.2015.05.003. Epub 2015 May 8. Clinical Outcomes and Prognostic Factors of Up-Front Autologous Stem Cell Transplantation in Patients with Extranodal Natural Killer/T Cell Lymphoma Yhim HY11, Kim JS2, Mun YC3, Moon JH4, Chae YS4, Park Y5, Jo JC6, Kim SJ7, Yoon DH8, Cheong JW2, Kwak JY1, Lee JJ9, Kim WS7, Suh C8, Yang DH10; Consortium for Improving Survival of Lymphoma Study.
    View PubMed
  • Ann Hematol. 2015 Sep;94(9):1485-92. doi: 10.1007/s00277-015-2389-9. Epub 2015 May 6. Comparison of consolidation strategies in acute myeloid leukemia: high-dose cytarabine alone versus intermediate-dose cytarabine combined with anthracyclines Kim DS11, Kang KW, Lee SR, Park Y, Sung HJ, Kim SJ, Choi CW, Kim BS.
    View PubMed
  • Oncotarget. 2015 Jul 10;6(19):17764-76. Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type Lee S11, Park HY2, Kang SY3, Kim SJ4, Hwang J2, Lee S5, Kwak SH6, Park KS6,7, Yoo HY5, Kim WS4, Kim JI1,2,8, Ko YH3.
    View PubMed
  • Korean J Intern Med. 2015 Jul;30(4):496-505. doi: 10.3904/kjim.2015.30.4.496. Epub 2015 Jun 29. Clinical features and outcomes of systemic amyloidosis with gastrointestinal involvement: a single-center experience Lim AY11, Lee JH1, Jung KS1, Gwag HB1, Kim do H1, Kim SJ1, Lee GY1, Kim JS2, Kim HJ3, Lee SY3, Lee JE1, Jeon ES1, Kim K1.
    View PubMed
  • Cancer Res Treat. 2015 Jul;47(3):448-57. doi: 10.4143/crt.2014.034. Epub 2014 Nov 3. Clinical Significance of Non-neutropenic Fever in the Management of Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP: Comparison with Febrile Neutropenia and Risk Factor Analysis Park S11, Kang CI2, Chung DR2, Peck KR2, Kim WS1, Kim SJ1.
    View PubMed
  • Anticancer Res. 2015 Jun;35(6):3333-40. Microarray Gene-expression Profiling Analysis Comparing PCNSL and Non-CNS Diffuse Large B-Cell Lymphoma Lim do H11, Kim WS2, Kim SJ3, Yoo HY4, Ko YH5.
    View PubMed
  • Genes Chromosomes Cancer. 2015 Jun;54(6):383-96. doi: 10.1002/gcc.22249. Epub 2015 Mar 31. Integrated Copy Number and Gene Expression Profiling Analysis of Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma Yoon H11, Park S, Ju H, Ha SY, Sohn I, Jo J, Do IG, Min S, Kim SJ, Kim WS, Yoo HY, Ko YH.
    View PubMed
  • J Hematol Oncol. 2015 May 14;8:49. doi: 10.1186/s13045-015-0142-4. The serum CXCL13 level is associated with the Glasgow Prognostic Score in extranodal NK/T-cell lymphoma patients Kim SJ11,2, Ryu KJ3, Hong M4, Ko YH5, Kim WS6.
    View PubMed
  • Ann Hematol. 2015 Apr;94(4):617-25. doi: 10.1007/s00277-014-2258-y. Epub 2014 Dec 3. Multicenter analysis of treatment outcomes in adult patients with lymphoblastic lymphoma who received hyper-CVAD induction followed by hematopoietic stem cell transplantation Jeong SH11, Moon JH, Kim JS, Yang DH, Park Y, Cho SG, Kwak JY, Eom HS, Won JH, Hong JS, Oh SY, Lee HS, Kim SJ.
    View PubMed
  • Cancer Res Treat. 2015 Apr;47(2):173-81. doi: 10.4143/crt.2014.055. Epub 2014 Oct 28. Treatment Outcomes of Rituximab Plus Hyper-CVAD in Korean Patients with Sporadic Burkitt or Burkitt-like Lymphoma: Results of a Multicenter Analysis Hong J11, Kim SJ2, Ahn JS3, Song MK4, Kim YR5, Lee HS6, Yhim HY7, Yoon DH8, Kim MK9, Oh SY10, Park Y11, Mun YC12, Do YR13, Ryoo HM14, Lee JJ3, Lee JH1, Kim WS2, Suh C8.
    View PubMed
  • Leuk Lymphoma. 2015 Apr;56(4):1020-6. doi: 10.3109/10428194.2014.946027. Epub 2014 Aug 20. Clinical outcome and prognosis of patients with primary sinonasal tract diffuse large B-cell lymphoma treated with rituximab-cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy: a study by the Consortium for Improving Survival of Lymphoma Lee GW11, Go SI, Kim SH, Hong J, Kim YR, Oh S, Kim SY, Do YR, Lee H, Lee SI, Bae SH, Oh SY, Song MK, Lee WS, Lee B, Kim JS, Kim MK, Kang HJ, Ahn JS, Yhim HY, Kim HJ, Kim SJ, Kim WS, Suh C; Consortium for Improving Survival of Lymphoma (CISL) study group.
    View PubMed
  • Clin Lymphoma Myeloma Leuk. 2015 Apr;15(4):227-35. doi: 10.1016/j.clml.2014.12.007. Epub 2014 Dec 12. The t(11;14)(q13;q32) Trans location as a Poor Prognostic Parameter for Autologous Stem Cell Transplantation in Myeloma Patients With Extramedullary Plasmacytoma Shin HJ11, Kim K2, Lee JJ3, Song MK1, Lee EY4, Park SH4, Kim SH5, Jang MA5, Kim SJ6, Chung JS1.
    View PubMed
  • Anticancer Res. 2015 Apr;35(4):2465-74. The Clinical Significance of Activated p-AKT Expression in Peripheral T-cell Lymphoma Hong JY11, Hong ME2, Choi MK3, Chang W4, Do IG5, Jo JS5, Jung SH6, Park S7, Kim SJ7, Ko YH2, Kim WS8.
    View PubMed
  • Haematologica. 2015 Mar;100(3):e106-9. doi: 10.3324/haematol.2014.116087. Epub 2014 Dec 5. Serum survivin and vascular endothelial growth factor in extranodal NK/T-cell lymphoma, nasal type: implications for a potential new prognostic indicator Kim SJ11, Hong M2, Do IG2, Lee SH3, Ryu KJ4, Yoo HY5, Hong JY6, Ko YH2, Kim WS7.
    View PubMed
  • Ann Oncol. 2015 Mar;26(3):548-55. doi: 10.1093/annonc/mdu556. Epub 2014 Dec 4. EBV-positive diffuse large B-cell lymphoma in young adults: is this a distinct disease entity Hong JY11, Yoon DH2, Suh C2, Huh J3, Do IG4, Sohn I4, Jo J4, Jung SH5, Hong ME6, Yoon H6, Ko YH6, Kim SJ7, Kim WS8.
    View PubMed
  • Int J Hematol. 2015 Mar;101(3):273-8. doi: 10.1007/s12185-014-1728-2. Epub 2015 Jan 1. Clinical features and treatment outcomes of primary cutaneous B-cell lymphoma: a single-center analysis in South Korea Kim MJ11, Hong ME, Maeng CH, Jung HA, Hong JY, Choi MK, Kim SJ, Ko YH, Kim WS.
    View PubMed
  • Ann Hum Genet. 2015 Mar;79(2):99-107. doi: 10.1111/ahg.12101. Epub 2015 Jan 23. Asp58Ala is the Predominant Mutation of the TTR Gene in Korean Patients with Hereditary Transthyretin-Related Amyloidosis Jang MA11, Lee GY, Kim K, Kim SJ, Kim JS, Lee SY, Kim HJ, Jeon ES.
    View PubMed
  • Acta Haematol. 2015;133(2):179-82. doi: 10.1159/000362149. Epub 2014 Oct 11. Pilot Trial of Systemic Methotrexate plus R-CHOP Regimen with Intrathecal Methotrexate for Simultaneous Central Nervous System and Systemic Diffuse Large B Cell Lymphoma Yoo KH11, Lee JY, Lim SH, Ko YH, Kim SJ, Kim WS.
    View PubMed
  • Ann Hematol. 2015 Jan;94(1):71-8. doi: 10.1007/s00277-014-2171-4. Epub 2014 Aug 2. Induction treatment with SMILE and consolidation with autologous stem cell transplantation for newly diagnosed stage IV extranodal natural killer/T-cell lymphoma patients Kim SJ11, Park S, Kang ES, Choi JY, Lim do H, Ko YH, Kim WS.
    View PubMed
  • Ann Lab Med. 2015 Jan;35(1):149-51. doi: 10.3343/alm.2015.35.1.149. Epub 2014 Dec 8. Simultaneous Occurrence of Angioimmunoblastic T-cell Lymphoma and Plasma Cell Leukemia Jang MA11, Lee ST1, Kim HJ1, Kim S2, Kim SH1.
    View PubMed
  • Amyloid. 2014 Dec;21(4):261-6. doi: 10.3109/13506129.2014.960560. Epub 2014 Sep 24. Bortezomib, melphalan, and prednisolone combination chemotherapy for newly diagnosed light chain (AL) amyloidosis Lee JY11, Lim SH, Kim SJ, Lee GY, Lee JE, Choi JO, Kim JS, Kim HJ, Lee SY, Min JH, Jeon ES, Kim K.
    View PubMed
  • Vox Sang. 2014 Nov;107(4):407-15. doi: 10.1111/vox.12183. Epub 2014 Jul 31. Incidence and risk factors of poor mobilization in adult autologous peripheral blood stem cell transplantation: a single-centre experience Lee KH11, Jung SK, Kim SJ, Jang JH, Kim K, Kim WS, Jung CW, Kim DW, Kang ES.
    View PubMed
  • Ann Hematol. 2014 Nov;93(11):1895-901. doi: 10.1007/s00277-014-2137-6. Epub 2014 Jun 20. Concurrent chemoradiotherapy followed by L-asparaginase-containing chemotherapy, VIDL, for localized nasal extranodal NK/T cell lymphoma: CISL08-01 phase II study Kim SJ11, Yang DH, Kim JS, Kwak JY, Eom HS, Hong DS, Won JH, Lee JH, Yoon DH, Cho J, Nam TK, Lee SW, Ahn YC, Suh C, Kim WS.
    View PubMed
  • Eur J Haematol. 2014 Nov;93(5):414-21. doi: 10.1111/ejh.12377. Epub 2014 Jun 14. Comparison of outcomes after autologous stem cell transplantation between myeloma patients with skeletal and soft tissue plasmacytoma Shin HJ11, Kim K, Lee JW, Song MK, Lee JJ, Lee HS, Lee WS, Kim SJ, Chung JS.
    View PubMed
  • Support Care Cancer. 2014 Oct;22(10):2669-75. doi: 10.1007/s00520-014-2256-6. Epub 2014 Apr 26. Impact of dose modification on intravenous Bortezomib-induced peripheral neuropathy in multiple myeloma patients Cho J11, Kang D, Lee JY, Kim K, Kim SJ.
    View PubMed
  • Leuk Lymphoma. 2014 Oct;55(10):2395-7. doi: 10.3109/10428194.2014.880429. Epub 2014 Mar 7. Spinal cord compression in multiple myeloma: a single center experience Jung HA11, Cho SH, Kim SJ, Jang JH, Kim WS, Jung CW, Kim K.
    View PubMed
  • Leuk Lymphoma. 2014 Sep;55(9):2196-8. doi: 10.3109/10428194.2013.871279. Epub 2014 Feb 17. Dexamethasone, methotrexate, ifosfamide, L-asparaginase and etoposide (SMILE) chemotherapy for relapsed or refractory adult lymphoblastic lymphoma Chang WJ11, Ko YH, Kim SJ, Kim WS.
    View PubMed
  • Ann Hematol. 2014 Sep;93(9):1571-7. doi: 10.1007/s00277-014-2067-3. Epub 2014 Apr 12. Early response-based intensification of primary therapy in newly diagnosed multiple myeloma patients who are eligible for autologous stem cell transplantation: phase II study Ahn SY11, Jung SH, Joo YD, Lee WS, Lee SM, Choi CW, Kim SJ, Kim K, Lee JJ; Korean Multiple Myeloma Working Party.
    View PubMed
  • Onco Targets Ther. 2014 Sep 26;7:1717-22. doi: 10.2147/OTT.S67380. eCollection 2014. Brentuximab vedotin for relapsed or refractory CD30+Hodgkin lymphoma: a multicenter analysis from Asia Yang QM11, Hong JY2, Ko YH3, Lin SY4, Au WY4, Choi MK5, Park S6, Kim SJ6, Kim WS6.
    View PubMed
  • Acta Haematol. 2014;132(2):226-32. Thalidomide, Cyclophosphamide and Dexamethasone Induction Therapy: Feasibility for Myeloma Patients Destined for Autologous Stem Cell Transplantation Chang WJ1, Kang ES, Lee ST, Kim SH, Kim DW, Kim SJ, Kim K.
    View PubMed
  • Support Care Cancer. 2014 Aug;22(8):2039-48. doi: 10.1007/s00520-014-2174-7. Epub 2014 Mar 5. Predictors of mortality attributable to Clostridium difficile infection in patients with underlying malignancy Yoon YK11, Kim MJ, Sohn JW, Kim HS, Choi YJ, Kim JS, Kim ST, Park KH, Kim SJ, Kim BS, Shin SW, Kim YH, Park Y.
    View PubMed
  • Anticancer Res. 2014 Aug;34(8):4299-306. Renal Insufficiency in Newly-diagnosed Multiple Myeloma: Analysis According to International Myeloma Working Group Consensus Statement Park S11, Han B2, Kim K3, Kim SJ1, Jang JH1, Kim WS1, Jung CW1.
    View PubMed
  • Biomed Res Int. 2014;2014:437852. doi: 10.1155/2014/437852. Epub 2014 Jul 10. Comparison of the Freiburg and Charlson Comorbidity Indices in Predicting Overall Survival in Elderly Patients with Newly Diagnosed Multiple Myeloma Kim SM11, Kim MJ1, Jung HA1, Kim K1, Kim SJ1, Jang JH1, Kim WS1, Jung CW1.
    View PubMed
  • Cancer Res Treat. 2014 Jul;46(3):307-11. doi: 10.4143/crt.2014.46.3.307. Epub 2014 Jul 15. Unusual Manifestation of Intravascular Large B-Cell Lymphoma: Severe Hypercalcemia with Parathyroid Hormone-Related Protein Ha JM11, Kim E, Lee WJ, Hwang JW, Yune S, Ko YH, Choi JY, Kim SJ, Kim WS.
    View PubMed
  • Mayo Clin Proc. 2014 Jun;89(6):781-9. doi: 10.1016/j.mayocp.2014.01.013. Epub 2014 Apr 3. Cardiac Amyloidosis Without Increased Left Ventricular Wall Thickness Lee GY11, Kim K2, Choi JO1, Kim SJ2, Kim JS3, Choe YH4, Grogan MA5, Jeon ES6.
    View PubMed
  • Biomed Res Int. 2014;2014:245247. doi: 10.1155/2014/245247. Epub 2014 Jun 23. Changes in Osteoblastic Activity in Patient Who Received Bortezomib as Second Line Treatment for Plasma Cell Myeloma: A Prospective Multicenter Study Eom KS11, Kim SJ2, Lee JJ3, Suh C4, Kim JS5, Yoon SS6, Kim BS7, Kang HJ8, Choi YJ9, Kim CS10, Kim YS11, Kwak JY12, Kim YJ1, Joo YD13, Mun YC14, Jo DY15, Park JS16, Park CY17, Kim SH18, Min CK1.
    View PubMed
  • Acta Haematol. 2014;131(4):193-9. doi: 10.1159/000354839. Epub 2013 Nov 26. Positive Correlation between Baseline PET or PET/CT Findings and Clinical Parameters in Multiple Myeloma Patients Park S11, Lee SJ, Chang WJ, Maeng CH, Hong JY, Choi MK, Kim YS, Jung CW, Jang JH, Kim SJ, Kim WS, Choi JY, Kim K.
    View PubMed
  • Nat Genet. 2014 Apr;46(4):371-5. doi: 10.1038/ng.2916. Epub 2014 Mar 2. A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma Yoo HY11, Sung MK2, Lee SH3, Kim S4, Lee H4, Park S5, Kim SC5, Lee B5, Rho K6, Lee JE6, Cho KH7, Kim W4, Ju H8, Kim J4, Kim SJ9, Kim WS9, Lee S4, Ko YH10.
    View PubMed
  • Acta Haematol. 2014;131(3):156-61. doi: 10.1159/000353787. Epub 2013 Oct 31. Matched-Pair Analysis Comparing the Outcomes of T Cell/Histiocyte-Rich Large B Cell Lymphoma and Diffuse Large B Cell Lymphoma in Patients Treated with Rituximab-CHOP Kim YS11, Ji JH, Ko YH, Kim SJ, Kim WS.
    View PubMed
  • Ann Hematol. 2014 Mar;93(3):437-47. doi: 10.1007/s00277-013-1884-0. Epub 2013 Aug 24. Gene expression profiles for the prediction of progression-free survival in diffuse large B cell lymphoma: results of a DASL assay Kim SJ11, Sohn I, Do IG, Jung SH, Ko YH, Yoo HY, Paik S, Kim WS.
    View PubMed
  • Br J Haematol. 2014 Mar;164(5):745-8. doi: 10.1111/bjh.12670. Epub 2013 Nov 18. Central nervous system multiple myeloma: a different cytogenetic profile Chang WJ11, Kim SJ, Kim K.
    View PubMed
  • Hum Pathol. 2014 Mar;45(3):556-64. doi: 10.1016/j.humpath.2013.10.023. Epub 2013 Oct 31. CD798 and MYD88 mutations in diffuse Large B-cell Lymphoma Kim Y11, Ju H2, Kim DH3, Yoo HY4, Kim SJ5, Kim WS5, Ko YH6.
    View PubMed
  • Nutr Cancer. 2014;66(2):225-33. doi: 10.1080/01635581.2014.867065. Epub 2014 Jan 9. Effect of Nutritional Status on Survival Outcome of Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP Park S11, Han B, Cho JW, Woo SY, Kim S, Kim SJ, Kim WS.
    View PubMed
  • Anticancer Res. 2014 Feb;34(2):1037-45. Prognostic Factor Analysis in Core-Binding Factor-positive Acute Myeloid Leukemia Jung HA11, Maeng CH, Park S, Kim SJ, Kim K, Jang JH, Jung CW.
    View PubMed
  • Acta Haematol. 2014;131(1):18-27. doi: 10.1159/000351060. Epub 2013 Sep 10. Clinical Features and Treatment Outcomes of Intravascular Large B-Cell Lymphoma: A Single-Center Experience in Korea Hong JY11, Kim HJ, Ko YH, Choi JY, Jung CW, Kim SJ, Kim WS.
    View PubMed
  • Ann Hematol. 2014 Jan;93(1):113-21. doi: 10.1007/s00277-013-1893-z. Epub 2013 Sep 12. Lenalidomide with dexamethasone treatment for relapsed/refractory myeloma patients in Korea-experience from 110 patients Kim K11, Kim SJ, Voelter V, Suh C, Yoon SS, Lee JJ, Kwak JY, Ryoo HM, Kim YS, Moon JH, Park SK, Kim SH, Mun YC, Kim JS, Eom HS, Jo DY, Jun HJ, Kim KH, Lee JO, Lee JH, Min CK; Korean Multiple Myeloma Working Party (KMMWP).
    View PubMed
  • Ann Hematol. 2014 Jan;93(1):99-105. doi: 10.1007/s00277-013-1952-5. Epub 2013 Nov 16. DCEP for relapsed or refractory multiple myeloma after therapy with novel agents Park S11, Lee SJ, Jung CW, Jang JH, Kim SJ, Kim WS, Kim K.
    View PubMed
  • Ann Oncol. 2014 Jan;25(1):182-8. doi: 10.1093/annonc/mdt530. The impact of activated p-AKT expression on clinical outcomes in diffuse large B-cell lymphoma: a clinicopathological study of 262 cases Hong JY11, Hong ME, Choi MK, Kim YS, Chang W, Maeng CH, Park S, Lee SJ, Do IG, Jo JS, Jung SH, Kim SJ, Ko YH, Kim WS.
    View PubMed
  • Cancer Res Treat. 2014 Jan;46(1):104-7. doi: 10.4143/crt.2014.46.1.104. Epub 2014 Jan 15. Primary Follicular Lymphoma in a Male Breast: A Case Report Jung SP11, Han KM2, Kim SJ3, Nam SJ4, Bae JW1, Lee JE4.
    View PubMed
  • Invest New Drugs. 2013 Dec;31(6):1514-21. doi: 10.1007/s10637-013-0015-z. Epub 2013 Aug 24. A phase I study of everolimus and CHOP in newly diagnosed peripheral T-cell lymphomas Kim SJ11, Kang HJ, Kim JS, Eom HS, Huh J, Ko YH, Lee J, Yim DS, Lee SY, Park WS, Yang WI, Lee SS, Suh C, Kim WS.
    View PubMed
  • Amyloid. 2013 Dec;20(4):204-11. doi: 10.3109/13506129.2013.824417. Epub 2013 Aug 5. Autologous stem cell transplantation in light-chain amyloidosis patients: a single-center experience in Korea Kim SJ11, Lee GY, Jang HR, Choi JO, Kim JS, Kim HJ, Lee SY, Min JH, Jeon ES, Kim K.
    View PubMed
  • Eur J Cancer. 2013 Nov;49(16):3486-96. doi: 10.1016/j.ejca.2013.07.006. Epub 2013 Aug 1. Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: Analysis from the Asia Lymphoma Study Group Kim SJ11, Hsu C, Song YQ, Tay K, Hong XN, Cao J, Kim JS, Eom HS, Lee JH, Zhu J, Chang KM, Reksodiputro AH, Tan D, Goh YT, Lee J, Intragumtornchai T, Chng WJ, Cheng AL, Lim ST, Suh C, Kwong YL, Kim WS.
    View PubMed
  • J Hematol Oncol. 2013 Nov 16;6:86. doi: 10.1186/1756-8722-6-86. Extranodal natural killer/T-cell lymphoma involving the gastrointestinal tract: analysis of clinical features and outcomes from the Asia Lymphoma study group Kim SJ11, Jung HA, Chuang SS, Hong H, Guo CC, Cao J, Hong XN, Suzuki R, Kang HJ, Won JH, Chng WJ, Kwong YL, Suh C, Song YQ, Zhu J, Tay K, Lim ST, Suzumiya J, Lin TY, Kim WS; Asia Lymphoma Study Group.
    View PubMed
  • Lancet Oncol. 2013 Nov;14(12):e548-61. doi: 10.1016/S1470-2045(13)70450-9. Management of B-cell non-Hodgkin lymphoma in Asia: resource-stratified guidelines Tan D11, Tan SY, Lim ST, Kim SJ, Kim WS, Advani R, Kwong YL.
    View PubMed
  • Int J Hematol. 2013 Sep;98(3):346-54. doi: 10.1007/s12185-013-1403-z. Epub 2013 Jul 19. Treatment outcome of relapsed/refractory primary central nervous system diffuse large B-cell lymphoma: a single-center experience of autologous stem cell transplantation Choi MK11, Kang ES, Kim DW, Ko YH, Seok H, Park JH, Pyo DH, Hoon Lim D, Kim SJ, Kim WS.
    View PubMed
  • Ann Hematol. 2013 Aug;92(8):1101-10. doi: 10.1007/s00277-013-1728-y. Epub 2013 Apr 5. Escalated daunorubicin dosing as an induction treatment for Philadelphia-negative adult acute lymphoblastic leukemia Lee SM11, Lee WS, Shin HJ, Lee JJ, Sohn SK, Moon JH, Eom HS, Won JH, Lee KH, Lee JH, Kim DY, Yoon SS, Kim I, Jung CW, Kim SJ, Kim H, Lee JH, Ryoo HM, Lee GW, Kim SH, Mun YC, Kim MK, Joo YD; Korean Society of Hematology Adult ALL working party.
    View PubMed
  • Jpn J Clin Oncol. 2013 Jun;43(6):676-80. doi: 10.1093/jjco/hyt047. Epub 2013 Apr 5. Unusual Presentation of Ewing Sarcoma in the Adrenal Gland: A Secondary Malignancy from a Survivor of Burkitt Lymphoma Lim SH11, Lee JY, Lee JY, Kim JH, Choi KH, Hyun JY, Ko YH, Lee J, Kim SJ, Kim WS.
    View PubMed
  • J Clin Oncol. 2013 Jun 10;31(17):2103-9. doi: 10.1200/JCO.2012.46.5203. Epub 2013 May 6. Multicenter Phase II Study of Bendamustine Plus Rituximab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma Ohmachi K11, Niitsu N, Uchida T, Kim SJ, Ando K, Takahashi N, Takahashi N, Uike N, Eom HS, Chae YS, Terauchi T, Tateishi U, Tatsumi M, Kim WS, Tobinai K, Suh C, Ogura M.
    View PubMed
  • Acta Haematol. 2013;129(1):10-7. doi: 10.1159/000341284. Epub 2012 Sep 8. Isolation of Side Population Cells in B-Cell Non-Hodgkin's Lymphomas Lee MR11, Ju HJ, Kim BS, Ko YH, Kim WS, Kim SJ.
    View PubMed
  • Eur J Cancer. 2012 Nov;48(17):3223-31. doi: 10.1016/j.ejca.2012.06.003. Epub 2012 Jul 4. Bortezomib in combination with CHOP as first-line treatment for patients with stage III/IV peripheral T-cell lymphomas: A multicentre, single-arm, phase 2 trial Kim SJ11, Yoon DH, Kang HJ, Kim JS, Park SK, Kim HJ, Lee J, Ryoo BY, Ko YH, Huh J, Yang WI, Kim HK, Min SK, Lee SS, Do IG, Suh C, Kim WS; Consortium for Improving Survival of Lymphoma (CISL) investigators.
    View PubMed
  • Ann Hematol. 2012 Nov;91(11):1747-56. doi: 10.1007/s00277-012-1516-0. Epub 2012 Jun 28. Prognostic relevance of pretreatment quality of life in diffuse large B-cell lymphoma patients treated with rituximab-CHOP: Results from a prospective cohort study Jung HA11, Park S, Cho JH, Kim S, Ko YH, Kim SJ, Kim WS.
    View PubMed
  • Int J Hematol. 2012 Nov;96(5):631-7. doi: 10.1007/s12185-012-1200-0. Epub 2012 Oct 12. Waldeyer's ring marginal zone B cell lymphoma: are the clinical and prognostic features nodal or extranodal A study by the Consortium for Improving Survival of Lymphoma (CISL) Oh SY11, Kim WS, Kim JS, Kim SJ, Lee S, Lee DH, Lee SI, Kang HJ, Choi CW, Park J, Song MK, Kim HJ, Kwon JH, Kwak JY, Bae SH, Park BB, Do YR, Lee HS, Jeong SH, Suh C, Kim HJ.
    View PubMed
  • Blood. 2012 Oct 11;120(15):2973-80. doi: 10.1182/blood-2012-05-431460. Epub 2012 Aug 23. SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group Kwong YL11, Kim WS, Lim ST, Kim SJ, Tang T, Tse E, Leung AY, Chim CS.
    View PubMed
  • Thromb Res. 2012 Sep;130(3):e6-12. doi: 10.1016/j.thromres.2012.03.019. Epub 2012 Apr 14. Incidence, risk factors and clinical features of venous thromboembolism in newly diagnosed lymphoma patients: Results from a prospective cohort study with Asian population Park LC11, Woo SY, Kim S, Jeon H, Ko YH, Kim SJ, Kim WS.
    View PubMed
  • J Hematol Oncol. 2012 Aug 13;5:49. Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL) Kim YR11, Kim JS, Min YH, Hyunyoon D, Shin HJ, Mun YC, Park Y, Do YR, Jeong SH, Park JS, Oh SY, Lee S, Park EK, Jang JS, Lee WS, Lee HW, Eom H, Ahn JS, Jeong JH, Baek SK, Kim SJ, Kim WS, Suh C.
    View PubMed
  • Leuk Lymphoma. 2012 Aug;53(8):1515-24. doi: 10.3109/10428194.2012.659735. Epub 2012 Mar 1. Non-bacterial infections in Asian patients treated with alemtuzumab: a retrospective study of the Asian Lymphoma Study Group Kim SJ11, Moon JH, Kim H, Kim JS, Hwang YY, Intragumtornchai T, Issaragrisil S, Kwak JY, Lee JJ, Won JH, Reksodiputro AH, Lim ST, Cheng AL, Kim WS, Kwong YL.
    View PubMed
  • Int J Cancer. 2012 Jul 1;131(1):235-43. doi: 10.1002/ijc.26352. Epub 2011 Aug 30. Matched-pair analysis comparing the outcomes of primary breast and nodal diffuse large B-cell lymphoma in patients treated with rituximab plus chemotherapy Yhim HY11, Kim JS, Kang HJ, Kim SJ, Kim WS, Choi CW, Eom HS, Kim JA, Lee JH, Won JH, Shim H, Huh J, Lee DH, Suh C, Kwak JY.
    View PubMed
  • Am J Hematol. 2012 Jul;87(7):663-8. doi: 10.1002/ajh.23213. Epub 2012 May 28. Type II enteropathy-associated T-cell lymphoma: A multicenter analysis from the Asia Lymphoma Study Group Tse E11, Gill H, Loong F, Kim SJ, Ng SB, Tang T, Ko YH, Chng WJ, Lim ST, Kim WS, Kwong YL.
    View PubMed
  • Leuk Lymphoma. 2012 May;53(5):807-11. doi: 10.3109/10428194.2011.635857. Epub 2011 Dec 7. Pilot trial of yttrium-90 ibritumomab tiuxetan consolidation following rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone chemotherapy in patients with limited-stage, bulky diffuse large B-cell lymphoma Yang DH11, Kim WS, Kim SJ, Kim JS, Kwak JY, Chung JS, Oh SY, Suh C, Lee JJ.
    View PubMed
  • Acta Haematol. 2012;127(3):129-34. doi: 10.1159/000333139. Epub 2012 Jan 12. Endoscopic Findings in Mantle Cell Lymphoma with Gastrointestinal Tract Involvement Kim JH11, Jung HW, Kang KJ, Min BH, Lee JH, Chang DK, Kim YH, Son HJ, Rhee PL, Kim JJ, Rhee JC, Kim SJ, Kim WS, Ko YH, Kim JY.
    View PubMed
  • Ann Hematol. 2012 Feb;91(2):223-33. doi: 10.1007/s00277-011-1297-x. Epub 2011 Jul 26. Clinical features and outcomes of Hodgkin's lymphoma in Korea: Consortium for Improving Survival of Lymphoma (CISL) Won YW11, Kwon JH, Lee SI, Oh SY, Kim WS, Kim SJ, Won JH, Kim KH, Park SK, Kim JS, Suh C, Yoon DH, Park JS, Kim MK, Kim H, Kang HJ, Mun YC, Kwak JY, Kim HJ, Eom HS.
    View PubMed
  • Invest New Drugs. 2012 Feb;30(1):368-75. doi: 10.1007/s10637-010-9523-2. Epub 2010 Aug 24. Dose modification of alemtuzumab in combination with dexamethasone, cytarabine, and cisplatin in patients with relapsed or refractory peripheral T-cell lymphoma: analysis of efficacy and toxicity Kim SJ11, Kim K, Park Y, Kim BS, Huh J, Ko YH, Park K, Suh C, Kim WS.
    View PubMed
  • Acta Haematol. 2012;127(2):100-4. doi: 10.1159/000333113. Epub 2011 Dec 15. Primary Thyroid Marginal Zone B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue Type: Clinical Manifestation and Outcome of a Rare Disease - Consortium for Improving Survival of Lymphoma Study Oh SY11, Kim WS, Kim JS, Kim SJ, Lee S, Lee DH, Kang HJ, Song MK, Kim HJ, Kwon JH, Kwak JY, Park BB, Do YR, Jeong SH, Suh C.
    View PubMed
  • Leuk Lymphoma. 2012 Jan;53(1):173-5. doi: 10.3109/10428194.2011.608452. Epub 2011 Sep 23. Bone involvement in patients with stage IV diffuse large B-cell lymphoma: does it have a prognostic value Lee HY1, Kim SJ, Kim K, Ko YH, Kim WS.
    View PubMed
  • Leuk Lymphoma. 2012 Jan;53(1):19-25. doi: 10.3109/10428194.2011.603448. Epub 2011 Sep 6. B cell homeostasis and the development of chronic graft-versus-host disease: implications for B cell-depleting therapy Kim SJ11, Won JH.
    View PubMed
  • Acta Haematol. 2011;126(2):79-86. doi: 10.1159/000327255. Epub 2011 May 4. Pretreatment Serum Level of 15-kDa Granulysin Might Have a Prognostic Value in Patients with Diffuse Large B Cell Lymphoma Park Y11, Choi YJ, Park SJ, Lee SR, Sung HJ, Park KH, Kim SJ, Choi CW, Jung KY, Kim BS.
    View PubMed
  • J Hematol Oncol. 2011 Aug 15;4:34. doi: 10.1186/1756-8722-4-34. Lymphopenia is an important prognostic factor in peripheral T-cell lymphoma (NOS) treated with anthracycline-containing chemotherapy Kim YR11, Kim JS, Kim SJ, Jung HA, Kim SJ, Kim WS, Lee HW, Eom HS, Jeong SH, Park JS, Cheong JW, Min YH.
    View PubMed
  • BMC Cancer. 2011 Jul 29;11:321. doi: 10.1186/1471-2407-11-321. Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL) Kim SJ11, Choi CW, Mun YC, Oh SY, Kang HJ, Lee SI, Won JH, Kim MK, Kwon JH, Kim JS, Kwak JY, Kwon JM, Hwang IG, Kim HJ, Lee JH, Oh S, Park KW, Suh C, Kim WS.
    View PubMed
  • Ann Hematol. 2011 May;90(5):539-46. doi: 10.1007/s00277-010-1104-0. Epub 2010 Oct 20. Secondary central nervous system (CNS) involvement in patients with diffuse large B-cell lymphoma: a therapeutic dilemma Kim SJ11, Oh SY, Kim JS, Kim H, Lee GW, Won JH, Shin HJ, Yang DH, Choi CW, Park J, Kim WS, Suh C.
    View PubMed
  • Jpn J Clin Oncol. 2011 Mar;41(3):353-7. doi: 10.1093/jjco/hyq194. Epub 2010 Oct 14. Low-dose Acyclovir is Effective for Prevention of Herpes Zoster in Myeloma Patients Treated with Bortezomib: A Report from the Korean Multiple Myeloma Working Party (KMMWP) Retrospective Study Kim SJ11, Kim K, Do YR, Bae SH, Yang DH, Lee JJ.
    View PubMed
  • Ann Oncol. 2011 Feb;22(2):411-6. doi: 10.1093/annonc/mdq393. Epub 2010 Aug 2. Immunoglobulin D multiple myeloma: response to therapy, survival, and prognostic factors in 75 patients Kim MK11, Suh C, Lee DH, Min CK, Kim SJ, Kim K, Moon JH, Yoon SS, Lee GW, Kang HJ, Kim SH, Choi CW, Eom HS, Kwak JY, Kim HJ, Mun YC, Bang SM, Lee K, Shin HJ, Lee JH; Korean Multiple Myeloma Working Party.
    View PubMed
  • Blood. 2011 Feb 10;117(6):1958-65. doi: 10.1182/blood-2010-06-288480. Epub 2010 Dec 9. Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: surgical resection followed by chemotherapy versus chemotherapy alone Kim SJ11, Kang HJ, Kim JS, Oh SY, Choi CW, Lee SI, Won JH, Kim MK, Kwon JH, Mun YC, Kwak JY, Kwon JM, Hwang IG, Kim HJ, Park J, Oh S, Huh J, Ko YH, Suh C, Kim WS.
    View PubMed
  • Leuk Lymphoma. 2011 Feb;52(2):317-20. doi: 10.3109/10428194.2010.529203. Epub 2010 Nov 11. Treatment of patients with refractory diffuse large B-cell lymphoma or mantle cell lymphoma with alemtuzumab, alone or in combination with cytotoxic chemotherapy Yi JH1, Kim SJ, Ko YH, Kim WS.
    View PubMed
  • Leuk Lymphoma. 2011 Feb;52(2):205-13. doi: 10.3109/10428194.2010.542261. Hypoxia-associated protein expression in primary central nervous system diffuse large B-cell lymphoma: does it predict prognosis Kim JA11, Kim SJ, Do IG, Jin J, Nam DH, Ko YH, Kim K, Kim WS.
    View PubMed
  • Jpn J Clin Oncol. 2010 Dec;40(12):1147-53. doi: 10.1093/jjco/hyq111. Epub 2010 Jul 20. Prognostic Significance of Serum Vascular Endothelial Growth Factor Per Platelet Count in Unresectable Advanced Gastric Cancer Patients Seo HY11, Park JM, Park KH, Kim SJ, Oh SC, Kim BS, Kim YH, Kim JS.
    View PubMed
  • Int J Hematol. 2010 Dec;92(5):690-6. doi: 10.1007/s12185-010-0720-8. Epub 2010 Nov 18. Treatment of localized extranodal NK/T cell lymphoma, nasal type Kim SJ11, Kim WS.
    View PubMed
  • Cancer Genet Cytogenet. 2010 Dec;203(2):215-21. doi: 10.1016/j.cancergencyto.2010.08.022. GSTT1 copy number gain is a poor predictive marker for escalated-dose imatinib treatment in chronic myeloid leukemia: genetic predictive marker found using array comparative genomic hybridization Koh Y11, Kim DY, Park SH, Jung SH, Park E, Kim HJ, Sohn SK, Joo YD, Kim SJ, Shin HJ, Kim SH, Song HS, Chung J, Kim I, Yoon SS, Kim BK, Shin SH, Chung YJ, Park S.
    View PubMed
  • Haematologica. 2010 Nov;95(11):1935-42. doi: 10.3324/haematol.2010.026104. Epub 2010 Jul 27. Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II study Kim SJ11, Lee JW, Jung CW, Min CK, Cho B, Shin HJ, Chung JS, Kim H, Lee WS, Joo YD, Yang DH, Kook H, Kang HJ, Ahn HS, Yoon SS, Sohn SK, Min YH, Min WS, Park HS, Won JH.
    View PubMed
  • Cancer Sci. 2010 Nov;101(11):2443-7. doi: 10.1111/j.1349-7006.2010.01698.x. Stage IV marginal zone B-cell lymphoma - prognostic factors and the role of rituximab: Consortium for Improving Survival of Lymphoma (CISL) study Oh SY11, Kim WS, Kim JS, Kim SJ, Lee S, Lee DH, Won JH, Hwang IG, Kim MK, Lee SI, Chae YS, Yang DH, Kang HJ, Choi CW, Park J, Kim HJ, Kwon JH, Lee HS, Lee GW, Eom HS, Kwak JY, Suh C, Kim HJ.
    View PubMed
  • J Bone Miner Metab. 2010 Nov;28(6):713-8. doi: 10.1007/s00774-010-0203-2. Epub 2010 Jul 6. Insufficient bilateral femoral subtrochanteric fractures in a patient receiving imatinib mesylate Yang KH11, Park SY, Park SW, Lee SH, Han SB, Jung WK, Kim SJ.
    View PubMed
  • Qual Life Res. 2010 Oct;19(8):1097-103. doi: 10.1007/s11136-010-9670-0. Epub 2010 May 5. Chemotherapy-related polyneuropathy may deteriorate quality of life in patients with B-cell lymphoma Kim BJ11, Park HR, Roh HJ, Jeong DS, Kim BS, Park KW, Cho SC, So YT, Oh SY, Kim SJ.
    View PubMed
  • Int J Hematol. 2010 Oct;92(3):510-7. doi: 10.1007/s12185-010-0680-z. Epub 2010 Sep 14. Multiple mucosa-associated lymphoid tissue organs involving marginal zone B cell lymphoma: organ-specific relationships and the prognostic factors. Consortium for improving survival of lymphoma study Oh SY11, Kim WS, Kim JS, Kim SJ, Lee S, Lee DH, Won JH, Hwang IG, Kim MK, Lee SI, Chae YS, Yang DH, Kang HJ, Choi CW, Park J, Kim HJ, Kwon JH, Lee HS, Lee GW, Eom HS, Kwak JY, Lee WS, Suh C, Kim HJ.
    View PubMed
  • Ann Hematol. 2010 Oct;89(10):1011-8. doi: 10.1007/s00277-010-0978-1. Epub 2010 May 7. Clinical features and treatment outcomes of lymphoplasmacytic lymphoma: a single center experience in Korea Won YW11, Kim SJ, Kim K, Ko YH, Kim WS.
    View PubMed
  • Leuk Res. 2010 Sep;34(9):1175-9. doi: 10.1016/j.leukres.2010.02.010. Epub 2010 Mar 5. Clinical features and prognostic relevance of ovarian involvement in non-Hodgkin's lymphoma: A Consortium for Improving Survival of Lymphoma (CISL) report Yun J11, Kim SJ, Won JH, Choi CW, Eom HS, Kim JS, Kim MK, Kwak JY, Kim WS, Suh C.
    View PubMed
  • Hematol Oncol. 2010 Jun;28(2):57-61. doi: 10.1002/hon.905. F-18-FDG uptake and its clinical relevance in primary gastric lymphoma Yi JH11, Kim SJ, Choi JY, Ko YH, Kim BT, Kim WS.
    View PubMed
  • BMC Cancer. 2010 Jun 22;10:321. doi: 10.1186/1471-2407-10-321. Clinical outcomes and prognostic factors in patients with breast diffuse large B cell lymphoma; Consortium for Improving Survival of Lymphoma (CISL) study Yhim HY11, Kang HJ, Choi YH, Kim SJ, Kim WS, Chae YS, Kim JS, Choi CW, Oh SY, Eom HS, Kim JA, Lee JH, Won JH, Shim H, Lee JJ, Sung HJ, Kim HJ, Lee DH, Suh C, Kwak JY.
    View PubMed
  • Int J Hematol. 2010 Jun;91(5):886-91. doi: 10.1007/s12185-010-0580-2. Epub 2010 May 8. A randomized trial of preemptive therapy for prevention of cytomegalovirus disease after allogeneic hematopoietic stem cell transplantation Kim ST11, Lee MH, Kim SY, Kim SJ, Kim DH, Jang JH, Kim K, Kim WS, Jung CW.
    View PubMed
  • Ann Oncol. 2010 May;21(5):1058-63. doi: 10.1093/annonc/mdp412. Epub 2009 Oct 22. When do we need central nervous system prophylaxis in patients with extranodal NK/T-cell lymphoma, nasal type Kim SJ11, Oh SY, Hong JY, Chang MH, Lee DH, Huh J, Ko YH, Ahn YC, Kim HJ, Suh C, Kim K, Kim WS.
    View PubMed
  • Am J Hematol. 2010 May;85(5):362-3. doi: 10.1002/ajh.21663. Clinicopathological features and outcome of late relapses of natural killer cell lymphomas 10-29 years after initial remission Au WY1, Kim SJ, Yiu HH, Ngan RK, Loong F, Kim WS, Kwong YL.
    View PubMed
  • Bone Marrow Transplant. 2010 Apr;45(4):801-2. doi: 10.1038/bmt.2009.240. Epub 2009 Sep 21. Excessive toxicity of once daily i.v. BU, melphalan and thiotepa followed by auto SCT on patients with non-Hodgkin's lymphoma Lee SC1, Kim SJ, Lee DH, Kim WS, Suh C, Won JH.
    View PubMed
  • Invest New Drugs. 2010 Apr;28(2):171-7. doi: 10.1007/s10637-009-9260-6. Epub 2009 May 7. Phase II study of Gemcitabine for treatment of patients with advanced stage marginal zone B-cell lymphoma: Consortium for Improving Survival of Lymphoma (CISL) trial Oh SY11, Kim WS, Lee DH, Kim SJ, Kim SH, Ryoo BY, Kang HJ, Choi YJ, Chung JS, Kim HJ, Suh C.
    View PubMed
  • Int J Hematol. 2010 Apr;91(3):456-63. doi: 10.1007/s12185-010-0536-6. Epub 2010 Mar 3. Improved treatment outcome of primary mediastinal large B-cell lymphoma after introduction of rituximab in Korean patients Ahn HK11, Kim SJ, Yun J, Yi JH, Kim JH, Won YW, Kim K, Ko YH, Kim WS.
    View PubMed
  • Cancer Genet Cytogenet. 2010 Mar;197(2):117-21. doi: 10.1016/j.cancergencyto.2009.11.008. Molecular cytogenetic analysis of Korean patients with Waldenstrom macroglobulinemia Bang SM11, Seo JW, Park KU, Kim SJ, Kim K, Kim SH, Cho SR, Kim HC, Song J, Kim JS, Kim KH, Lee JH, Lee JJ, Shin MG, Suh C, Chi HS, Oh DY, Won JH, Kim HJ, Yoon SS, Lee DS; Korean Multiple Myeloma Working Party (KMMWP).
    View PubMed
  • Leuk Res. 2010 Mar;34(3):294-300. doi: 10.1016/j.leukres.2009.08.024. Epub 2009 Sep 16. The suggestion of a risk stratification system for febrile neutropenia in patients with hematologic disease Park Y11, Kim DS, Park SJ, Seo HY, Lee SR, Sung HJ, Park KH, Choi IK, Kim SJ, Oh SC, Seo JH, Choi CW, Kim BS, Shin SW, Kim YH, Kim JS.
    View PubMed
  • Med Oncol. 2010 Mar;27(1):91-7. doi: 10.1007/s12032-009-9178-z. Epub 2009 Feb 24. Phosphorylated epidermal growth factor receptor and cyclooxygenase-2 expression in localized non-small cell lung cancer Kim SJ11, Rabbani ZN, Dong F, Vollmer RT, Schreiber EG, Dewhirst MW, Vujaskovic Z, Kelley MJ.
    View PubMed
  • Ann Hematol. 2010 Feb;89(2):201-6. doi: 10.1007/s00277-009-0807-6. Epub 2009 Aug 25. Low incidence of clinically apparent thromboembolism in Korean patients with multiple myeloma treated with thalidomide Koh Y11, Bang SM, Lee JH, Yoon HJ, Do YR, Ryoo HM, Lee N, Kim SJ, Kim K, Yoon SS, Won JH, Mun YC, Lee MH, Rhee KH, Kim HJ, Eom H, Kim MK, Shin HC; Korean Multiple Myeloma Working Party.
    View PubMed
  • J Clin Oncol. 2010 Feb 1;28(4):e54-5. doi: 10.1200/JCO.2009.23.7560. Epub 2009 Nov 16. Gastric Recurrence of Extramedullary Granulocytic Sarcoma After Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia Choi ER11, Ko YH, Kim SJ, Jang JH, Kim K, Kang WK, Jung CW, Kim DH.
    View PubMed
  • Echocardiography. 2010 Feb;27(2):E23-6. doi: 10.1111/j.1540-8175.2009.01059.x. Primary Angiosarcoma of the Pulmonary Trunk Mimicking Pulmonary Thromboembolism Kim JB11, Kim SH, Lim SY, Roh SY, Cho GY, Song HJ, Park S, Lee J, Kim SJ.
    View PubMed
  • J Clin Oncol. 2009 Dec 10;27(35):6027-32. doi: 10.1200/JCO.2009.23.8592. Epub 2009 Nov 2. Phase II Trial of Concurrent Radiation and Weekly Cisplatin Followed by VIPD Chemotherapy in Newly Diagnosed, Stage IE to IIE, Nasal, Extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma Study Kim SJ11, Kim K, Kim BS, Kim CY, Suh C, Huh J, Lee SW, Kim JS, Cho J, Lee GW, Kang KM, Eom HS, Pyo HR, Ahn YC, Ko YH, Kim WS.
    View PubMed
  • Acta Haematol. 2010;123(1):48-54. doi: 10.1159/000262291. Epub 2009 Dec 2. Clinical Features and Treatment Outcomes of Non-Hodgkin's Lymphomas Involving Rare Extranodal Sites: A Single-Center Experience Yun J11, Kim SJ, Kim JA, Kong JH, Lee SH, Kim K, Ko YH, Kim WS.
    View PubMed
  • Ann Hematol. 2009 Nov;88(11):1099-106. doi: 10.1007/s00277-009-0729-3. Epub 2009 Mar 14. Treatment outcome of adult patients with Burkitt lymphoma: results using the LMB protocol in Korea Choi MK11, Jun HJ, Lee SY, Kim KH, Lim do H, Kim K, Ko YH, Kim WS, Kim SJ.
    View PubMed
  • Acta Haematol. 2009;122(4):200-10. doi: 10.1159/000253027. Epub 2009 Oct 29. Clinical Features and Survival Outcomes in Patients with Multiple Myeloma: Analysis of Web-Based Data from the Korean Myeloma Registry Kim SJ11, Kim K, Kim BS, Jo DY, Kang HJ, Kim JS, Mun YC, Kim CS, Sohn SK, Eom HS, Kwak JY, Shim H, Yoon HJ, Jin JY, Min CK, Shin H, Won JH, Lee JJ, Kwon JH, Joo YD, Do YR, Kim SH, Oh S, Suh C, Lee J, Yoon SS, Kim MK, Bang SM, Ryoo HM, Kim BS, Kim H, Kim HJ, Kim YS, Park CW, Lee GW, Shin HJ, Park SK, Park JS, Kim HY, Lee DS, Lee JH; Korean Multiple Myeloma Working Party.
    View PubMed
  • Leuk Lymphoma. 2009 Jul;50(7):1119-25. doi: 10.1080/10428190902926999. Clinical features and treatment outcomes of adult B- and T-lymphoblastic lymphoma: results of multicentre analysis in Korea Chang MH11, Kim SJ, Kim K, Oh SY, Lee DH, Huh J, Ko YH, Choi CW, Yang DH, Won JH, Kim WS, Suh C.
    View PubMed
  • Cancer Res Treat. 2009 Jun;41(2):104-7. doi: 10.4143/crt.2009.41.2.104. Epub 2009 Jun 30. Complete Remission in a Patient with Human Herpes Virus-8 Negative Multicentric Castleman Disease Using CHOP Chemotherapy Seo HY11, Kim EB, Kim JW, Shin BK, Kim SJ, Kim BS.
    View PubMed
  • Med Oncol. 2009;26(1):45-8. doi: 10.1007/s12032-008-9079-6. Epub 2008 Jun 10. Rituximab-induced acute thrombocytopenia: a case report and review of the literature Yi JH11, Kim SJ, Ahn HK, Lee SJ, Chang MH, Kim WS.
    View PubMed
  • Ann Oncol. 2009 Feb;20(2):390-2. doi: 10.1093/annonc/mdn726. Alemtuzumab and DHAP (A-DHAP) is effective for relapsed peripheral T-cell lymphoma, unspecified: interim results of a phase II prospective study Kim SJ1, Kim K, Kim BS, Suh C, Huh J, Ko YH, Kim WS.
    View PubMed
  • Acta Haematol. 2008;120(4):211-6. doi: 10.1159/000193223. Epub 2009 Jan 20. Increased Serum 90K and Galectin-3 Expression Are Associated with Advanced Stage and a Worse Prognosis in Diffuse Large B-Cell Lymphomas Kim SJ11, Lee SJ, Sung HJ, Choi IK, Choi CW, Kim BS, Kim JS, Yu W, Hwang HS, Kim IS.
    View PubMed
  • Eur J Haematol. 2008 Sep;81(3):177-84. doi: 10.1111/j.1600-0609.2008.01099.x. Epub 2008 May 27. Serum BAFF predicts prognosis better than APRIL in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP chemotherapy Kim SJ11, Lee SJ, Choi IY, Park Y, Choi CW, Kim IS, Yu W, Hwang HS, Kim BS.
    View PubMed
  • Leuk Lymphoma. 2008 Aug;49(8):1623-6. doi: 10.1080/10428190802129934. Serum level of soluble human leukocyte antigen-G molecules in non-Hodgkin lymphoma: Does it have a prognostic value Park Y1, Kim SJ, Lee SJ, Kim BS.
    View PubMed
  • Clin Lymphoma Myeloma. 2008 Aug;8(4):237-40. doi: 10.3816/CLM.2008.n.031. Bortezomib and the increased incidence of herpes zoster in patients with multiple myeloma Kim SJ11, Kim K, Kim BS, Lee HJ, Kim H, Lee NR, Nam SH, Kwon JH, Kim HJ, Sohn SK, Won JH, Lee JH, Suh C, Yoon SS, Kim HJ, Kim I, Do YR, Lee WS, Joo YD, Shin HJ; Korean Multiple Myeloma Working Party.
    View PubMed